Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Jiang

Showing results (61-70 of 580) with videos related to

Pageof 58
Sort By:
Future Virology|March 24, 2020
Development of SARS vaccines and therapeutics is still neededShibo Jiang, Lu Lu, Lanying Du
Frontiers in Immunology|January 13, 2018
Single-Domain Antibodies As Therapeutics against Human Viral DiseasesYanling Wu, Shibo Jiang, Tianlei Ying
Signal Transduction and Targeted Therapy|November 30, 2023
SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spreadXinling Wang, Lu Lu, Shibo Jiang
Signal Transduction and Targeted Therapy|March 16, 2023
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccinesQiao Wang, Lujia Sun, Shibo Jiang
Current Pharmaceutical Design|April 12, 2002
Peptide and non-peptide HIV fusion inhibitorsShibo Jiang, Qian Zhao, Asim K Debnath
Cellular & Molecular Immunology|February 7, 2020
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndromeShibo Jiang, Shuai Xia, Tianlei Ying, et al.
Vaccines|September 2, 2020
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus VaccinesNaru Zhang, Chaoqun Li, Shibo Jiang, et al.
Expert Opinion on Therapeutic Patents|January 12, 2017
Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)Wen Li, Lu Lu, Weihua Li, et al.
Frontiers in Cellular and Infection Microbiology|September 12, 2022
Corrigendum: Advancement in the development of therapeutics against Zika virus infectionKangchen Li, Qianting Ji, Shibo Jiang, et al.
Biochemical and Biophysical Research Communications|November 9, 2004
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entryYuxian He, Yusen Zhou, Pamela Siddiqui, et al.
Pageof 58

Showing results (61-70 of 580) with videos related to

Sort By:
Pageof 58
Future Virology|March 24, 2020
Development of SARS vaccines and therapeutics is still neededShibo Jiang, Lu Lu, Lanying Du
Frontiers in Immunology|January 13, 2018
Single-Domain Antibodies As Therapeutics against Human Viral DiseasesYanling Wu, Shibo Jiang, Tianlei Ying
Signal Transduction and Targeted Therapy|November 30, 2023
SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spreadXinling Wang, Lu Lu, Shibo Jiang
Signal Transduction and Targeted Therapy|March 16, 2023
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccinesQiao Wang, Lujia Sun, Shibo Jiang
Current Pharmaceutical Design|April 12, 2002
Peptide and non-peptide HIV fusion inhibitorsShibo Jiang, Qian Zhao, Asim K Debnath
Cellular & Molecular Immunology|February 7, 2020
A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndromeShibo Jiang, Shuai Xia, Tianlei Ying, et al.
Vaccines|September 2, 2020
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus VaccinesNaru Zhang, Chaoqun Li, Shibo Jiang, et al.
Expert Opinion on Therapeutic Patents|January 12, 2017
Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015)Wen Li, Lu Lu, Weihua Li, et al.
Frontiers in Cellular and Infection Microbiology|September 12, 2022
Corrigendum: Advancement in the development of therapeutics against Zika virus infectionKangchen Li, Qianting Ji, Shibo Jiang, et al.
Biochemical and Biophysical Research Communications|November 9, 2004
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entryYuxian He, Yusen Zhou, Pamela Siddiqui, et al.
Pageof 58